TSMC strengthens its bifurcated process technology development approach with A14, A13, N2U, A16, A12, and N2X.

Taiwanese semiconductor foundry TSMC has announced its most advanced process technology called A16. Scheduled to enter production in the second half of 2026, it is the company’s 1.6nm production node.

TSMC (TWSE: 2330, NYSE: TSM) today debuted its latest innovation in its most advanced process technology at the Company’s 2026 North America Technology Symposium. TSMC’s new A13 process is a direct ...

FORT DETRICK, Md. – A process developed by the Medical Research and Development Command’s Medical Technology Transfer Office to help inventors ensure their biomedical technologies are ready for ...

With the FDA expecting to approve 10–20 Cell and Gene Therapies (CGTs) annually by 2025, it is evident that the field will continue to hold immense commercial and medical opportunities. To harness ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. The Lone Star College Process Technology Associate of ...

Observations and experiments during research activities often lead to discoveries and inventions. An invention is any useful process, machine, composition of matter, or any new or useful improvement ...

Biopharmaceutical downstream processing requires precise control of multiple unit operations—from chromatography and filtration to viral inactivation—to ensure product quality and therapeutic efficacy ...